Hot-melt extruded in situ gelling systems (MeltDrops Technology): Formulation development, in silico modelling and in vivo studies
European Journal of Pharmaceutics and Biopharmaceutics · 2023
DOI: 10.1016/j.ejpb.2023.05.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2023. Verfasst von Srushti M Tambe und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Technology, Department of Pharmaceutical Sciences and Technology, Mumbai 400019, India. Hauptthemen laut MEDLINE: Technology, Pharmaceutical, Hot Melt Extrusion Technology. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 87 Literaturangaben. Gefördert von: All India Council for Technical Education, Science and Engineering Research Board, Department of Science and Technology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
In situ gelling systems (ISGS) can prolong retention time and bioavailability of ophthalmic solutions. The complexity and cost of ISGS avert their industrial scale-up and clinical implementation. In this study, we demonstrate novel application of hot-melt extrusion (HME) technology for continuous manufacturing of ISGS (MeltDrops Technology). Timolol maleate (TIM) and dorzolamide hydrochloride (DRZ) loaded MeltDrops were successfully developed using HME for glaucoma management, thereby resolving issues with batch manufacturing of ISGS, prolonging retention time thus improving bioavailability. The MeltDrops technology involves one-step, i.e., passing all the ingredients through an extruder at a screw speed between 20 and 50 rpm and barrel temperature of 80 °C. The comparative evaluation of MeltDrops and batch-processed ISGS demonstrated that MeltDrops exhibited better physical and chemical content uniformity. The extrusion temperature and screw speed were critical factors influencing content uniformity and properties of the MeltDrops. MeltDrops showed sustained drug release for > 12 h in vitro (TIM = 83.07%; DRZ = 60.43%, 12 h) versus marketed eyedrops. The developed MeltDrops followed Peppas-Sahlin model, combining Fickian diffusion and swelling processes. The in vivo study in New Zealand rabbits revealed superior effectiveness and safety of the MeltDrops as compared to the marketed eyedrops. Herein we conclude, MeltDrops would serve as a cutting-edge platform technology that can be used to manufacture various ISGS with one-step processability, cost-effectiveness, and improved product quality, which are otherwise processed by batch manufacturing that involves numerous complex processing steps.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Chemical Technology, Department of Pharmaceutical Sciences and Technology, Mumbai 400019, India.
- Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.
- Institute of Chemical Technology, Department of Pharmaceutical Sciences and Technology, Mumbai 400019, India. Electronic address: pd.amin@ictmumbai.edu.in.
Förderung
- All India Council for Technical Education
- Science and Engineering Research Board
- Department of Science and Technology, Ministry of Science and Technology, India
Zitieren
APA
Tambe, S. M., Jain, D. D., Hasmukh Mehta, C., T, A., Yogendra Nayak, U., & Amin, P. D. (2023). Hot-melt extruded in situ gelling systems (MeltDrops Technology): Formulation development, in silico modelling and in vivo studies. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2023.05.008
Vancouver
Tambe SM, Jain DD, Hasmukh Mehta C, T A, Yogendra Nayak U, Amin PD. Hot-melt extruded in situ gelling systems (MeltDrops Technology): Formulation development, in silico modelling and in vivo studies. European Journal of Pharmaceutics and Biopharmaceutics. 2023. doi:10.1016/j.ejpb.2023.05.008
BibTeX
@article{Tambe2023,
author = {Tambe, Srushti M and Jain, Divya D and Hasmukh Mehta, Chetan and T, Ashwini and Yogendra Nayak, Usha and Amin, Purnima D},
title = {Hot-melt extruded in situ gelling systems (MeltDrops Technology): Formulation development, in silico modelling and in vivo studies},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2023},
doi = {10.1016/j.ejpb.2023.05.008}
}
EUVIMED